Pricing Log in Create free account
Friday 6 November 2026 Export NEO’s income statement to Excel — free account

NeoGenomics, Inc.

NEO Healthcare Diagnostics & Research

NeoGenomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $727.3 million, up 10.1% from fiscal 2024.

Revenue
+11.4%
EPS
+72.1%
Free cash flow
−3,724.2%
Total debt
+10.9%

Quarter to September 2026, against a year earlier

16.31 0.18 −1.09%
Market cap
$2.1B
P/E
0.0×
Fwd P/E
−68.4×
Dividend yield
—
F-score
4/9
Altman Z
1.79
Beneish M
−2.68
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

NeoGenomics, Inc. (NEO) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, NeoGenomics, Inc. (NEO) trades at a P/B ratio of 2.7×. Over the past ten years it has ranged from 0.7× (July 2025) to 9.4× (February 2021); the current reading is higher than 41% of that period. That is below the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.8× (22.15%)
FY2024 2.3× 8.80%
FY2023 2.1× 87.92%
FY2022 1.1× (69.37%)
FY2021 3.7× (56.14%)
FY2020 8.4× 45.38%
FY2019 5.8× 71.90%
FY2018 3.4× (16.35%)
FY2017 4.0× (1.46%)
FY2016 4.1× 79.77%

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.9× 22.51%
Jun 2026 2.4× 108.15%
Mar 2026 1.2× (35.78%)
Dec 2025 1.8× 52.27%
43 more quarters

Against its own ten years

Low 0.7× High 9.4×
Ten-year median 3.5×
Current reading's percentile 45

P/B ratio against peers

Company P/B ratio
FRNM Freenome, Inc compare n/m
OPK OPKO Health, Inc. compare 1.2×
VCYT Veracyte, Inc. compare 1.4×
CSTL Castle Biosciences, Inc. compare 2.2×
NEO NeoGenomics, Inc. 2.7×
PSNL Personalis, Inc. compare 7.9×
WGS GeneDx Holdings Corp. compare 7.9×
CDNA CareDx, Inc. compare 8.6×
ADPT Adaptive Biotechnologies Corporation compare 23.5×
Diagnostics & Research industry median 3.4×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on NEO